Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:20
Sanofi Is Exploring Acquisition of Cancer Drugmaker Mirati
French pharmaceutical firm Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc., according to people
2023-10-06 17:51